Table 3. Correlation between AC007255.1 expression and clinicopathologic characteristics of ESCA patients.
Characteristics | High expression (80) | Low expression (81) | χ2 | p value |
---|---|---|---|---|
Age | 3.933 | 0.047 | ||
<60 | 30 | 44 | ||
≥60 | 50 | 37 | ||
Stage | 21.144 | <0.001 | ||
Stage I | 9 | 8 | ||
Stage II | 21 | 48 | ||
Stage III | 30 | 19 | ||
Stage IV | 7 | 1 | ||
unknown | 13 | 5 | ||
Pathology T stage | 18.654 | 0.001 | ||
T1 | 19 | 8 | ||
T2 | 10 | 27 | ||
T3 | 40 | 37 | ||
T4 | 0 | 4 | ||
unknown | 11 | 5 | ||
Pathology N stage | 25.748 | <0.001 | ||
N0 | 18 | 48 | ||
N1 | 40 | 23 | ||
N2 | 6 | 3 | ||
N3 | 6 | 0 | ||
unknown | 10 | 7 | ||
Pathology M stage | 8.354 | 0.015 | ||
M0 | 53 | 68 | ||
M1 | 7 | 1 | ||
unknown | 20 | 12 | ||
Gender | 1.740 | 0.187 | ||
female | 8 | 15 | ||
male | 72 | 66 | ||
Race | 30.144 | <0.001 | ||
asian | 6 | 32 | ||
black or africanamerican | 1 | 4 | ||
white | 58 | 42 | ||
unknown | 15 | 3 |